The Bigfoot Unity Diabetes Management System, a smart pen cap system cleared by the U.S. Food and Drug Administration in May 2021, incorporates continuous glucose monitoring data, real-time glycemic alerts, and clinician-directed dose recommendations. This study analyzed real-world clinical outcomes data for an initial cohort ( = 58, from 13 clinics) managing multiple daily injection insulin therapy using the pen cap system for 6 months. We examined glycemic control, including hypoglycemia events and interaction with and use of the pen cap system. In a cohort mainly consisting of adults with type 2 diabetes and an average age of 62 years, the results demonstrate close adherence to established glycemic targets, including a relatively short amount of time spent in the hypoglycemic range.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577513 | PMC |
| http://dx.doi.org/10.2337/cd22-0126 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Tuberculosis Masquerading Foreign Body in Children.
Int J Mycobacteriol
October 2024
Faculty of Dentistry, Medical Sciences, Islamic Azad University, Tehran, Iran.
Foreign body aspiration (FBA) is a common issue in children, particularly boys, and can be life-threatening. Early removal of the foreign body (FB) leads to recovery, but delayed diagnosis may cause complications such as granuloma, recurrent pneumonia, and atelectasis. This condition often results from a child's curiosity, with factors such as inadequate swallowing reflex and activity during eating contributing to the risk.
View Article and Find Full Text PDFA Telehealth Program Using Continuous Glucose Monitoring and a Connected Insulin Pen Cap in Nursing Homes for Older Adults with Insulin-Treated Diabetes: The Trescasas Study.
Diabetes Technol Ther
November 2024
Department of Biostatistics, Harvard University, Boston, Massachusetts, USA.
To assess the impact and feasibility of a telehealth program using continuous glucose monitoring (CGM) and a connected insulin pen cap (CIPC) in nursing homes for older adults with insulin-treated diabetes. This multicenter, prospective, sequential, single-arm study consisted of three phases: (1) baseline, blind CGM (); (2) intervention 1, CGM () without alarms; and (3) intervention 2, CGM with alarms for hypo and hyperglycemia. Two telehealth visits from reference diabetes units were conducted to adjust antidiabetic treatments.
View Article and Find Full Text PDFObserved Glycemic and Psychosocial Benefits in the Prospective Bigfoot Unity Real World Study: A Six-Month Analysis.
J Clin Endocrinol Metab
November 2024
Abbott, 1820 McCarthy Blvd, Milpitas, Milpitas, CA 95035.
Context: The Bigfoot Unity Diabetes Management System integrates Abbott FreeStyle Libre 2 continuous glucose monitoring (CGM) data into a smart pen cap and mobile app enabling clinician-directed insulin dose recommendations and real-time alerts.
Objective: The objective was to analyze real world 6-month glycemic control in a prospective study for individuals using the System for multiple daily insulin injections (MDI).
Methods: We conducted a 6-month analysis from the BURST study (NCT05088265) of individuals with type 1 or type 2 diabetes (T2D).
Multiplex immunochromatographic test strip based on multicolor gold nanoparticles for the simultaneous detection of neomycin, penicillin, and chloramphenicol in food samples.
Food Chem
February 2025
Department of Chemistry, Faculty of Science and Technology, Rajamangala University of Technology Thanyaburi, Thanyaburi, Pathum Thani 12110, Thailand. Electronic address:
In this study, we demonstrated an approach for the development of multiplex immunochromatographic test strip (MICS) for neomycin (NEO), penicillin (PEN), and chloramphenicol (CAP) detection using three different-colored gold nanoparticles. The gold nanoparticles: gold nanospheres (red), gold nanostars (blue), and gold nanoflowers (black) were applied as labels for MICS fabrication. The proposed MICS achieved a clearly visible limit of detection with cut-off values of 500, 5, and 0.
View Article and Find Full Text PDF. This article details the development and use of a low-cost, custom RMST device for a patient with long COVID who had received positive airway flow support during ICU treatment. By sharing our successful management of respiratory muscle weakness in a severe COVID-19 patient, we aim to contribute to the broader conversation around effective long COVID management.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!